472
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Phosphatidylinositol 3-kinase/Akt Signaling Pathway Mediates Acupuncture-Induced Dopaminergic Neuron Protection and Motor Function Improvement in a Mouse Model of Parkinson's Disease

, , , , , , , & show all
Pages 562-569 | Received 01 Apr 2011, Published online: 19 Jul 2011

REFERENCES

  • Aleyasin, H., Rousseaux, M. W., Marcogliese, P. C., Hewitt, S. J., Irrcher, I., Joselin, A. P., et al. (2010). DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway. Proc Natl Acad Sci U S A, 107(7), 3186–91.
  • Chae, Y., Lee, H., Kim, H., Kim, C. H., Chang, D. I., Kim,K. M., et al. (2009). Parsing brain activity associated with acupuncture treatment in Parkinson's diseases. Mov Disord, 24(12), 1794–802.
  • Choi, Y. G., Park, J. H., Lim, S. (2009). Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced parkinsonism model. Neurosci Lett, 450(2), 92–6.
  • Cristian, A., Katz, M., Cutrone, E., Walker, R. H. (2005). Evaluation of acupuncture in the treatment of Parkinson's disease: a double-blind pilot study. Mov Disord, 20(9), 1185–8.
  • Crocker, S. J., Smith, P. D., Jackson-Lewis, V., Lamba, W. R., Hayley, S. P., Grimm, E., et al. (2003). Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci, 23(10), 4081–91.
  • De Rosa, R., Garcia, A. A., Braschi, C., Capsoni, S., Maffei, L., Berardi, N., (2005). Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci U S A, 102(10), 3811–6.
  • Gozes, I. (2001). Neuroprotective peptide drug delivery and development: potential new therapeutics. Trends Neurosci, 24(12), 700–5.
  • Grunblatt, E., Mandel, S., Youdim, M. B. (2000). Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP. Ann N Y Acad Sci, 899, 262–73.
  • Hirsch, E. C., Faucheux, B. A. (1998). Iron metabolism and Parkinson's disease. Mov Disord, 13 Suppl 1, 39–45.
  • Hirsch, E. C., Hunot, S., Damier, P., Faucheux, B. (1998). Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann Neurol, 44(3 Suppl 1), S115–20.
  • Huang, Y., Jiang, X., Zhuo, Y., Tang, A., Wik, G. (2009). Complementary acupuncture treatment increases cerebral metabolism in patients with Parkinson's disease. Int J Neurosci, 119(8), 1190–7.
  • Huang, Y., Jiang, X., Zhuo, Y., Wik, G. (2010). Complementary acupuncture in Parkinson's disease: a spect study. Int J Neurosci, 120(2), 150–4.
  • Hunot, S., Vila, M., Teismann, P., Davis, R. J., Hirsch, E. C., Przedborski, S., et al. (2004). JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A, 101(2), 665–70.
  • Jeon, S., Kim, Y. J., Kim, S. T., Moon, W., Chae, Y., Kang, M., et al. (2008). Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model. Proteomics, 8(22), 4822–32.
  • Kang, J. M., Park, H. J., Choi, Y. G., Choe, I. H., Park, J. H., Kim, Y. S., et al. (2007). Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model. Brain Res, 1131(1), 211–9.
  • Keith B. J., Franklin, G. P. The Mouse Brain in Stereotaxic Coordinates. California: Academic; 2008
  • Kim, S. T., Moon, W., Chae, Y., Kim, Y. J., Lee, H., Park, H. J. (2009). The effect of electroaucpuncture for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced proteomic changes in the mouse striatum. J Physiol Sci, 60(1), 27–34.
  • Kim, Y. K., Lim, H. H., Song, Y. K., Lee, H. H., Lim, S., Han, S. M., et al. (2005). Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats. Neurosci Lett, 384(1-2), 133–8.
  • Lam, Y. C., Kum, W. F., Durairajan, S. S., Lu, J. H., Man, S. C., Xu, M., et al. (2008). Efficacy and safety of acupuncture for idiopathic Parkinson's disease: a systematic review. J Altern Complement Med, 14(6), 663–71.
  • Liang, X. B., Liu, X. Y., Li, F. Q., (2002). Long-term high frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia 495 nigra and ventral tegmental area following medial forebrain bundle axotomy. Brain Research Molecular Brain Research, 108(1–2), 51–59.
  • Liang, X. B., Luo, Y., Liu, X. Y., (2003). Electro-acupuncture improves behavior and upregulates GDNF mRNA in MFB tran- 500 sected rats. Neuroreport, 14(8), 1177–1181.
  • Manning, B. D., & Cantley, L. C. (2007). AKT/PKB signaling: Navigating downstream. Cell, 129(7), 1261–1274.
  • Mouradian, M. M., Juncos, J. L., Serrati, C., (1987). Exercise and the antiparkinsonian response to levodopa. Clinical Neu- 505 ropharmacology, 10(4), 351–355.
  • Park, H. J., Lim, S., Joo, W. S., (2003). Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model. Experimental Neurology, 180(1), 93–98. 510
  • Park, Y., Chang, D., Lee, Y., (2007). The Study on the Effect of Acupuncture Treatment in Patients with Idiopathic Parkinson's Disease. Journal of Korean Acupuncture Society, 24, 43– 54.
  • Petzinger, G. M., Walsh, J. P., Akopian, G., (2007). Effects of treadmill exercise on dopaminergic transmission in the 515 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. Journal of Neuroscience, 27(20), 5291–5300.
  • Rajendran, P. R., Thompson, R. E., & Reich, S. G. (2001). The use of alternative therapies by patients with Parkinson's disease. Neu-520 rology, 57(5), 790–794.
  • Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., (2009). Initial clinical manifestations of Parkinson's disease: Features and pathophysiological mechanisms. Lancet Neurological, 8(12), 1128–1139. 525.
  • Rozas, G., Guerra, M. J., & Labandeira-Garcia, J. L. (1997). An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Research Brain Research Protocols, 2(1), 75–84.
  • Rozas, G., Lopez-Martin, E., Guerra, M. J., (1998). The over-530 all rod performance test in the MPTP-treated-mouse model of Parkinsonism. Journal of Neuroscience Methods, 83(2), 165–175.
  • Schapira, A. H. (2008). Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurological, 7(1), 97– 109.
  • Shulman, L. M., Wen, X., Weiner, W. J., (2002). Acupuncture 535 therapy for the symptoms of Parkinson's disease. Movement Disorders, 17(4), 799–802.
  • Wang, Y., Zhang, Y., Wei, Z., (2009). JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease. Journal of 540 Neurological Sciences, 285(1–2), 172– 177.
  • World Health Organization Western Pacific Region. (2008). WHO Standard Acupuncture Point Locations in the Western Pacific Region. Manila: WHO Regional Office for the Western Pacific.
  • Yang, Y., Gehrke, S., Haque, M. E., (2005). Inactivation of 545 Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proceedings of the National Academy of Sciences of the United States of America, 102(38), 13670–13675.
  • Yin, C. S., Jeong, H. S., Park, H. J., (2008). A proposed trans- 550 positional acupoint system in a mouse and rat model. Research in Veterinary Science, 84(2), 159–165.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.